Status:
COMPLETED
Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
Lead Sponsor:
Centre of Chinese Medicine, Georgia
Collaborating Sponsors:
Rea Rehabilitation Centre, Georgia
Conditions:
Bronchial Asthma
Eligibility:
All Genders
17-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether antiepileptic drug oxcarbazepine is effective in the treatment of chronic asthma.
Detailed Description
Effective therapy of asthma still remains quite serious problem. According GINA definition, asthma is an inflammatory disorder. Consequently, modern pharmacotherapy of asthma provides wide use of anti...
Eligibility Criteria
Inclusion
- Bronchial asthma has been known at least for 1 year
- Absence of long-term remissions of asthma (lasting more than 1 month)
- Poorly controlled asthma, due to various reasons
- Non-smokers
Exclusion
- Presence of concomitant severe diseases
- Allergy or adverse reactions to carbamazepine or oxcarbazepine
- Abnormal baseline haematology, blood chemistry or urinalysis
- Current use of long-acting beta-agonists
- Age younger than 16 years old
- Long-term history of smoking
- Pregnancy or lactating
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2002
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00142025
Start Date
September 1 2001
End Date
March 1 2002
Last Update
February 19 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.